Q2 2020 Holdings
Filed 2020-08-17 | 15 holdings | $34.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $25.5M | 844,680 | 74.4% |
| Beam Therapeutics(BEAM) | Common Stock | 07373V105 | $8.5M | 302,821 | 24.7% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $132.2K | 5,344,971 | 0.4% |
| Morphic Holding | Common Stock | 61775R105 | $80.5K | 2,975,582 | 0.2% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $43.2K | 3,320,608 | 0.1% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $16.6K | 1,371,494 | 0.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $13.6K | 2,602,739 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $9.3K | 1,497,448 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $9.1K | 1,375,907 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $7.4K | 2,005,249 | 0.0% |
| ObsEva | Common Stock | H5861P103 | $5.9K | 999,364 | 0.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $5.3K | 130,646 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $3.7K | 529,965 | 0.0% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $2.8K | 187,538 | 0.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $2.3K | 750,741 | 0.0% |